BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

894 related articles for article (PubMed ID: 12610426)

  • 1. [Anti-SSA/Ro and anti-SSB/La antibodies. What's new?].
    Meyer O
    Ann Med Interne (Paris); 2002 Dec; 153(8):520-9. PubMed ID: 12610426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subclass distribution of maternal and neonatal anti-Ro(SSA) and La(SSB) antibodies in congenital heart block.
    Tseng CE; Caldwell K; Feit S; Chan EK; Buyon JP
    J Rheumatol; 1996 May; 23(5):925-32. PubMed ID: 8724310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-52 kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen.
    Dorner T; Feist E; Wagenmann A; Kato T; Yamamoto K; Nishioka K; Burmester GR; Hiepe F
    J Rheumatol; 1996 Mar; 23(3):462-8. PubMed ID: 8832984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Ro (SSA) and anti-La (SSB) antibodies and complete congenital heart block.
    Finkelstein Y; Adler Y; Harel L; Nussinovitch M; Youinou P
    Ann Med Interne (Paris); 1997; 148(3):205-8. PubMed ID: 9255327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Ro/SSA and La/SSB antibodies.
    Franceschini F; Cavazzana I
    Autoimmunity; 2005 Feb; 38(1):55-63. PubMed ID: 15804706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune response in mothers of children with congenital and postnatally diagnosed isolated heart block: a population based study.
    Julkunen H; Miettinen A; Walle TK; Chan EK; Eronen M
    J Rheumatol; 2004 Jan; 31(1):183-9. PubMed ID: 14705240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between maternal and neonatal levels of antibodies to 48 kDa SSB(La), 52 kDa SSA(Ro), and 60 kDa SSA(Ro) in pregnancies complicated by congenital heart block.
    Buyon JP; Waltuck J; Caldwell K; Crawford B; Slade SG; Copel J; Chan EK
    J Rheumatol; 1994 Oct; 21(10):1943-50. PubMed ID: 7837164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Ro/SSA and -La/SSB antibodies in patients with connective tissue diseases.
    Yamagata H; Akizuki M; Tojo T; Homma M
    Scand J Rheumatol Suppl; 1986; 61():98-101. PubMed ID: 3495876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perinatal outcome of fetus with isolated congenital second degree atrioventricular block without maternal anti-SSA/Ro-SSB/La antibodies.
    Chang YL; Hsieh PC; Chang SD; Chao AS; Liang CC; Soong YK
    Eur J Obstet Gynecol Reprod Biol; 2005 Oct; 122(2):167-71. PubMed ID: 16219517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA typing of maternal HLA in congenital complete heart block: comparison with systemic lupus erythematosus and primary Sjögren's syndrome.
    Colombo G; Brucato A; Coluccio E; Compasso S; Luzzana C; Franceschini F; Quinzanini M; Scorza R
    Arthritis Rheum; 1999 Aug; 42(8):1757-64. PubMed ID: 10446878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ro(SSA) and La(SSB) antibodies in the clinical spectrum of Sjögren's syndrome.
    Alexander EL; Hirsch TJ; Arnett FC; Provost TT; Stevens MB
    J Rheumatol; 1982; 9(2):239-46. PubMed ID: 7097683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and laboratory aspects of Ro/SSA-52 autoantibodies.
    Defendenti C; Atzeni F; Spina MF; Grosso S; Cereda A; Guercilena G; Bollani S; Saibeni S; Puttini PS
    Autoimmun Rev; 2011 Jan; 10(3):150-4. PubMed ID: 20854935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-La/SSB antiidiotypic antibodies in maternal serum: a marker of low risk for neonatal lupus in an offspring.
    Stea EA; Routsias JG; Clancy RM; Buyon JP; Moutsopoulos HM; Tzioufas AG
    Arthritis Rheum; 2006 Jul; 54(7):2228-34. PubMed ID: 16802359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Ro (SSA) and anti-La (SSB) antibodies in lupus erythematosus and in Sjögren's syndrome.
    Lee LA
    Arch Dermatol; 1988 Jan; 124(1):61-2. PubMed ID: 3257370
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies: detection and treatment of first-degree atrioventricular block.
    Mevorach D; Elchalal U; Rein AJ
    Curr Opin Rheumatol; 2009 Sep; 21(5):478-82. PubMed ID: 19584727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic studies of anti-Ro (SSA) antibodies in families with rheumatoid arthritis.
    Tishler M; Moutsopoulos HM; Yaron M
    J Rheumatol; 1992 Feb; 19(2):234-6. PubMed ID: 1629820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New coupled-particle light-scattering assay for detection of Ro/SSA (52 and 60 kilodaltons) and La/SSB autoantibodies in connective tissue diseases.
    Bizzaro N; Bonelli F; Tonutti E; Tozzoli R; Villalta D
    Clin Diagn Lab Immunol; 2001 Sep; 8(5):922-5. PubMed ID: 11527804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. More to death than dying: apoptosis in the pathogenesis of SSA/Ro-SSB/La-associated congenital heart block.
    Clancy RM; Buyon JP
    Rheum Dis Clin North Am; 2004 Aug; 30(3):589-602, x. PubMed ID: 15261343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study.
    Martínez-Sánchez N; Pérez-Pinto S; Robles-Marhuenda Á; Arnalich-Fernández F; Martín Cameán M; Hueso Zalvide E; Bartha JL
    Immunol Res; 2017 Apr; 65(2):487-494. PubMed ID: 28138914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limiting dilution analysis of Epstein-Barr virus infectable B cells secreting anti-Ro/SSA and anti-La/SSB antibodies in neonatal lupus erythematosus and systemic lupus erythematosus.
    Isacovics B; Silverman ED
    J Autoimmun; 1993 Aug; 6(4):481-94. PubMed ID: 8216690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.